HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Gwenn A Garden Selected Research

Ataxin-7

3/2013Reduction of mutant ataxin-7 expression restores motor function and prevents cerebellar synaptic reorganization in a conditional mouse model of SCA7.
11/2011Spinocerebellar ataxia type 7 cerebellar disease requires the coordinated action of mutant ataxin-7 in neurons and glia, and displays non-cell-autonomous bergmann glia degeneration.
10/2006Bergmann glia expression of polyglutamine-expanded ataxin-7 produces neurodegeneration by impairing glutamate transport.
6/2002Polyglutamine-expanded ataxin-7 promotes non-cell-autonomous purkinje cell degeneration and displays proteolytic cleavage in ataxic transgenic mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Gwenn A Garden Research Topics

Disease

6Alzheimer Disease (Alzheimer's Disease)
01/2021 - 12/2013
5Neurodegenerative Diseases (Neurodegenerative Disease)
01/2021 - 06/2002
5Spinocerebellar Ataxias (Spinocerebellar Ataxia)
03/2013 - 06/2002
4Neoplasms (Cancer)
01/2022 - 07/2004
4Neuroinflammatory Diseases
11/2020 - 12/2010
3Disease Progression
07/2015 - 01/2008
2Stroke (Strokes)
01/2020 - 01/2019
2Mitochondrial Diseases (Mitochondrial Disease)
01/2019 - 07/2015
2Inflammation (Inflammations)
02/2016 - 01/2015
2X-Linked Bulbo-Spinal Atrophy
09/2014 - 02/2009
2Ataxia (Dyssynergia)
03/2013 - 10/2006
1Neurotoxicity Syndromes (Toxic Encephalopathy)
01/2022
1Multiple Sclerosis
01/2021
1Parkinson Disease (Parkinson's Disease)
01/2021
1Pathologic Processes
11/2020
1AIDS-Related Complex (ARC)
01/2020
1Hematologic Neoplasms (Hematological Malignancy)
01/2020
1Central Nervous System Diseases (CNS Diseases)
10/2016
1Autoimmune Diseases (Autoimmune Disease)
02/2016
1Dementia (Dementias)
08/2015
1Genomic Instability
01/2015
1Cerebellar Diseases (Cerebellar Syndrome)
11/2011
1Neurocognitive Disorders (Clerambault Syndrome)
10/2011
1Motor Neuron Disease (Primary Lateral Sclerosis)
02/2009
1Cone-Rod Dystrophies
01/2008
1Carotid Artery Diseases
10/2007
1Infections
08/2007
1Ischemia
06/2006
1Hemorrhage
03/2006
1Carotid Stenosis (Carotid Artery Stenosis)
03/2006
1Herpes Zoster
01/2004
1Herpes Zoster Oticus (Geniculate Neuralgia)
01/2004
1Facial Paralysis (Facial Palsy)
01/2004
1Gait Ataxia
06/2002

Drug/Important Bio-Agent (IBA)

6polyglutamineIBA
09/2014 - 06/2002
4Amyloid (Amyloid Fibrils)IBA
01/2021 - 07/2015
4Proteins (Proteins, Gene)FDA Link
04/2019 - 06/2002
4Ataxin-7IBA
03/2013 - 06/2002
3Presenilin-2IBA
01/2020 - 12/2013
3Presenilin-1IBA
01/2020 - 07/2015
3Transcription Factors (Transcription Factor)IBA
10/2011 - 07/2004
2Chimeric Antigen ReceptorsIBA
01/2022 - 01/2020
2MicroRNAs (MicroRNA)IBA
01/2021 - 02/2016
2Protein Isoforms (Isoforms)IBA
01/2019 - 07/2015
2Histones (Histone)IBA
01/2019 - 10/2013
2Biomarkers (Surrogate Marker)IBA
10/2016 - 02/2016
2Messenger RNA (mRNA)IBA
07/2015 - 08/2007
2Androgen Receptors (Androgen Receptor)IBA
09/2014 - 02/2009
2Peptide Hydrolases (Proteases)FDA Link
12/2013 - 08/2007
1CytokinesIBA
01/2020
1Caspase 3 (Caspase-3)IBA
01/2019
1Amyloid beta-PeptidesIBA
01/2019
1Apolipoprotein E4IBA
08/2015
1SynucleinsIBA
08/2015
1DNA-Binding Proteins (DNA Binding Protein)IBA
08/2015
1Tumor Suppressor Protein p53IBA
01/2015
1TamoxifenFDA LinkGeneric
03/2013
1Tumor Suppressor Proteins (Proteins, Tumor Suppressor)IBA
04/2012
1Glycoproteins (Glycoprotein)IBA
10/2011
1Amyloid Precursor Protein Secretases (beta-Secretase)IBA
12/2010
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
10/2007
1Nerve Growth Factors (Neurotrophins)IBA
06/2006
1LipidsIBA
03/2006
1Antiviral Agents (Antivirals)IBA
01/2004
1Acyclovir (Aciclovir)FDA LinkGeneric
01/2004

Therapy/Procedure

4Therapeutics
01/2020 - 01/2004
1Immunotherapy
01/2022